Literature DB >> 31050045

Astrocytes in neuroendocrine systems: An overview.

Alastair J MacDonald1, Josephine L Robb1, Nicole A Morrissey1, Craig Beall1, Kate L J Ellacott1.   

Abstract

A class of glial cell, astrocytes, is highly abundant in the central nervous system (CNS). In addition to maintaining tissue homeostasis, astrocytes regulate neuronal communication and synaptic plasticity. There is an ever-increasing appreciation that astrocytes are involved in the regulation of physiology and behaviour in normal and pathological states, including within neuroendocrine systems. Indeed, astrocytes are direct targets of hormone action in the CNS, via receptors expressed on their surface, and are also a source of regulatory neuropeptides, neurotransmitters and gliotransmitters. Furthermore, as part of the neurovascular unit, astrocytes can regulate hormone entry into the CNS. This review is intended to provide an overview of how astrocytes are impacted by and contribute to the regulation of a diverse range of neuroendocrine systems: energy homeostasis and metabolism, reproduction, fluid homeostasis, the stress response and circadian rhythms.
© 2019 British Society for Neuroendocrinology.

Entities:  

Keywords:  astrocyte; circadian; hypothalamus; metabolism; reproduction; stress

Mesh:

Year:  2019        PMID: 31050045     DOI: 10.1111/jne.12726

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  7 in total

1.  Sex Dimorphic Glucose Transporter-2 Regulation of Hypothalamic Astrocyte Glucose and Energy Sensor Expression and Glycogen Metabolism.

Authors:  Madhu Babu Pasula; Prabhat R Napit; Abdulrahman Alhamyani; Sagor C Roy; Paul W Sylvester; Khaggeswar Bheemanapally; Karen P Briski
Journal:  Neurochem Res       Date:  2022-09-29       Impact factor: 4.414

2.  Prenatal glucocorticoid exposure selectively impairs neuroligin 1-dependent neurogenesis by suppressing astrocytic FGF2-neuronal FGFR1 axis.

Authors:  Gee Euhn Choi; Chang Woo Chae; Mo Ran Park; Jee Hyeon Yoon; Young Hyun Jung; Hyun Jik Lee; Ho Jae Han
Journal:  Cell Mol Life Sci       Date:  2022-05-13       Impact factor: 9.207

3.  Enduring neuroimmunological consequences of developmental experiences: From vulnerability to resilience.

Authors:  Jack Reddaway; Nichola M Brydges
Journal:  Mol Cell Neurosci       Date:  2020-10-14       Impact factor: 4.314

Review 4.  The Properties and Functions of Glial Cell Types of the Hypothalamic Median Eminence.

Authors:  Richard W Clayton; Robin Lovell-Badge; Christophe Galichet
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-27       Impact factor: 6.055

5.  The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.

Authors:  Petra I Lorenzo; Eugenia Martin Vazquez; Livia López-Noriega; Esther Fuente-Martín; José M Mellado-Gil; Jaime M Franco; Nadia Cobo-Vuilleumier; José A Guerrero Martínez; Silvana Y Romero-Zerbo; Jesús A Perez-Cabello; Sabrina Rivero Canalejo; Antonio Campos-Caro; Christian Claude Lachaud; Alejandra Crespo Barreda; Manuel Aguilar-Diosdado; Eduardo García Fuentes; Alejandro Martin-Montalvo; Manuel Álvarez Dolado; Franz Martin; Gemma Rojo-Martinez; David Pozo; Francisco J Bérmudez-Silva; Valentine Comaills; José C Reyes; Benoit R Gauthier
Journal:  Theranostics       Date:  2021-05-12       Impact factor: 11.556

Review 6.  Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer's Disease and Its Neuropsychiatric Symptoms.

Authors:  Catia Scassellati; Antonio Carlo Galoforo; Ciro Esposito; Miriam Ciani; Giovanni Ricevuti; Cristian Bonvicini
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

7.  Blockade of Glial Connexin 43 Hemichannels Reduces Food Intake.

Authors:  Florent Guillebaud; Manon Barbot; Rym Barbouche; Jean-Michel Brézun; Kevin Poirot; Flora Vasile; Bruno Lebrun; Nathalie Rouach; Michel Dallaporta; Stéphanie Gaige; Jean-Denis Troadec
Journal:  Cells       Date:  2020-10-31       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.